Non-small cell lung cancer clinical trials

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer accounting for 80% to 85% of all lung cancer cases.¹

We are studying investigational medications across early-stage, locally advanced, and metastatic non-small cell lung cancer (NSCLC).

Non-small cell lung cancer (NSCLC) begins in the lining of the lungs and tends to develop and spread more slowly than small cell lung cancer. Through clinical trials, we are continuing our efforts to study investigational treatments for people with NSCLC.

There is a lot to consider when deciding whether to participate in a clinical trial. Any clinical trial includes risks, which the study doctor will review with you. Make sure you understand the risks before participating.

A woman speaking to a female doctor while walking down a hall.

Explore non-small cell lung cancer clinical trials that are enrolling volunteers

Below is a list of all available non-small cell lung cancer clinical trials. You can narrow the results by choosing options in the dropdown menus below. You can also sort results to show trials nearest to you by entering your city and state in the search field.

Female doctor listening to an older man's heart while a younger woman watches.

Resources for patients

For help understanding clinical trial listings and for other resources, visit our Patient Resources section.

Browse resources

Senior female patient in discussion with doctor during check up in exam room

About clinical trials

Learn what clinical trials are, how they work, and if you may be eligible to participate.

Learn more

Reference:
1. What Is Lung Cancer. American Cancer Society. Updated January 29, 2024. Accessed August 24, 2026. https://www.cancer.org/cancer/types/lung-cancer/about/what-is.html